{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:00:18Z","timestamp":1780401618943,"version":"3.54.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":233,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI170753\\u201301A1"],"award-info":[{"award-number":["1R01AI170753\\u201301A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015988","name":"National Institute for Research in Tuberculosis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015988","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2017-2590"],"award-info":[{"award-number":["2017-2590"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.crmicr.2025.100462","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:16:59Z","timestamp":1755962219000},"page":"100462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Enhancing diagnostic efficiency of pyrazinamide resistance in Mycobacterium tuberculosis via modified MGIT assay and genotypic correlation"],"prefix":"10.1016","volume":"9","author":[{"given":"Ananthi","family":"Rajendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Kabir","family":"Refaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Subramanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Karunaianantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhandapani","family":"RaviKumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemalatha","family":"Haribabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Gopalaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadivel","family":"Senthildevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanan Sivaramakrishnan","family":"Gomathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-2402","authenticated-orcid":false,"given":"Kannan","family":"Palaniyandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10150","key":"10.1016\/j.crmicr.2025.100462_bib0001","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.crmicr.2025.100462_bib0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5588\/ijtld.14.0305","article-title":"Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan","volume":"19","author":"Akhmetova","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"15","key":"10.1016\/j.crmicr.2025.100462_bib0003","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","author":"Allix-B\u00e9guec","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.crmicr.2025.100462_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00420","article-title":"Phthiocerol dimycocerosates from Mycobacterium tuberculosis increase the membrane activity of bacterial effectors and host receptors","volume":"10","author":"Augenstreich","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100462_bib0005","article-title":"Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia","volume":"34","author":"Balay","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"issue":"4","key":"10.1016\/j.crmicr.2025.100462_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00663-19","article-title":"Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy","volume":"10","author":"Bellerose","year":"2019","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.crmicr.2025.100462_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00535-21","article-title":"A Comprehensive map of Mycobacterium tuberculosis complex regions of difference","volume":"6","author":"Bespiatykh","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.crmicr.2025.100462_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-6-23","article-title":"Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology","volume":"6","author":"Brudey","year":"2006","journal-title":"BMC Microbiol."},{"issue":"26","key":"10.1016\/j.crmicr.2025.100462_bib0009","article-title":"More on treatment outcomes in multidrug-resistant tuberculosis","volume":"375","author":"Brust","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.crmicr.2025.100462_bib0010","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/AAC.00630-11","article-title":"Pyrazinamide susceptibility testing in mycobacterium tuberculosis: a systematic review with meta-analyses","volume":"55","author":"Chang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06306-1","article-title":"Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China","volume":"21","author":"Che","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.crmicr.2025.100462_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2012.02.004","article-title":"SITVITWEB - A publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology","volume":"12","author":"Demay","year":"2012","journal-title":"Infect. Genet. Evol."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100462_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00654-16","article-title":"Pyrazinamide is active against Mycobacterium tuberculosis cultures at neutral pH and low temperature","volume":"60","author":"Den Hertog","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06415-5","article-title":"Anti-tubercular activity of pyrazinamide is independent of trans-translation and rpsA","volume":"7","author":"Dillon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmicr.2025.100462_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-60327-999-4_10","article-title":"Spoligotyping for molecular epidemiology of the Mycobacterium tuberculosis complex","volume":"551","author":"Driscoll","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0016","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-016-3213-1","article-title":"In silico region of difference (RD) analysis of Mycobacterium tuberculosis complex from sequence reads using RD-Analyzer","volume":"17","author":"Faksri","year":"2016","journal-title":"BMC Genom."},{"issue":"12","key":"10.1016\/j.crmicr.2025.100462_bib0017","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.tips.2019.10.005","article-title":"Pharmacological and molecular mechanisms behind the sterilizing activity of pyrazinamide","volume":"40","author":"Gopal","year":"2019","journal-title":"Trends Pharmaco. Sci."},{"issue":"9","key":"10.1016\/j.crmicr.2025.100462_bib0018","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acsinfecdis.6b00070","article-title":"Pyrazinamide resistance is caused by two distinct mechanisms: prevention of coenzyme a depletion and loss of virulence factor synthesis","volume":"2","author":"Gopal","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"32","key":"10.1016\/j.crmicr.2025.100462_bib0019","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024571118","article-title":"Growth of Mycobacterium tuberculosis at acidic pH depends on lipid assimilation and is accompanied by reduced GAPDH activity","volume":"118","author":"Gouzy","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.crmicr.2025.100462_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S230774","article-title":"Detection of novel gene mutations associated with pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates in Southern China","volume":"13","author":"Hameed","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.crmicr.2025.100462_bib0021","series-title":"India TB Report 2016. TB India 2016 by RNTCP annual Report","year":"2016"},{"key":"10.1016\/j.crmicr.2025.100462_bib0022","unstructured":"Indian mutation catalogue. (2022). Indian catalogue of Mycobacterium tuberculosis mutations and their association with drug resistance-2022. https:\/\/www.nirt.res.in\/pdf\/Indian%20Mutation%20Catalogue%202022.pdf."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-58635-x","article-title":"Structure guided prediction of Pyrazinamide resistance mutations in pncA","volume":"10","author":"Karmakar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmicr.2025.100462_bib0024","doi-asserted-by":"crossref","unstructured":"Khan, M.T., Malik, S., Ali, S., Masood, N., Nadeem, T., Khan, A., & Afzal, M. (2019). Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. https:\/\/doi.org\/10.1186\/s12879-019-3764-2.","DOI":"10.1186\/s12879-019-3764-2"},{"issue":"9","key":"10.1016\/j.crmicr.2025.100462_bib0025","doi-asserted-by":"crossref","DOI":"10.1089\/mdr.2017.0234","article-title":"Prevalence of pyrazinamide resistance in Khyber Pakhtunkhwa, Pakistan","volume":"24","author":"Khan","year":"2018","journal-title":"Microb. Drug Resist."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100462_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002824","article-title":"Routine use of microbial whole genome sequencing in diagnostic and public health microbiology","volume":"8","author":"K\u00f6ser","year":"2012","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.crmicr.2025.100462_bib0027","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000001149","article-title":"Effect of metformin on plasma exposure of rifampicin, isoniazid, and pyrazinamide in patients on treatment for pulmonary tuberculosis","volume":"46","author":"Kumar","year":"2024","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.crmicr.2025.100462_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.00070-19","article-title":"The bewildering antitubercular action of pyrazinamide","volume":"84","author":"Lamont","year":"2020","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"W1","key":"10.1016\/j.crmicr.2025.100462_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab301","article-title":"Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation","volume":"49","author":"Letunic","year":"2021","journal-title":"Nucleic. Acids. Res."},{"issue":"January","key":"10.1016\/j.crmicr.2025.100462_bib0030","first-page":"1","article-title":"Characterization of pncA mutations and prediction of PZA resistance in Mycobacterium tuberculosis clinical isolates from Chongqing, China","volume":"11","author":"Li","year":"2021","journal-title":"Front. Microbiol."},{"issue":"FEB","key":"10.1016\/j.crmicr.2025.100462_bib0031","article-title":"Mutations in efflux pump Rv1258c (Tap) cause resistance to pyrazinamide, isoniazid, and streptomycin in Mycobacterium tuberculosis","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.crmicr.2025.100462_bib0032","doi-asserted-by":"crossref","first-page":"1016.e1","DOI":"10.1016\/j.cmi.2017.12.012","article-title":"Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China","volume":"24","author":"Liu","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0033","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-09079-5","article-title":"Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019","volume":"24","author":"Lv","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.crmicr.2025.100462_bib0034","author":"Maharaj"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005351","article-title":"Mycobacterial metabolic syndrome: lprG and Rv1410 regulate triacylglyceride levels, growth rate and virulence in Mycobacterium tuberculosis","volume":"12","author":"Martinot","year":"2016","journal-title":"PLoS. Pathog."},{"issue":"5","key":"10.1016\/j.crmicr.2025.100462_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01819-14","article-title":"Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study","volume":"5","author":"Miotto","year":"2014","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.crmicr.2025.100462_bib0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","article-title":"The action of antituberculosis drugs in short-course chemotherapy","volume":"66","author":"Mitchison","year":"1985","journal-title":"Tubercle"},{"issue":"6","key":"10.1016\/j.crmicr.2025.100462_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01916-20","article-title":"Atypical genetic basis of pyrazinamide resistance in monoresistant mycobacterium tuberculosis","volume":"65","author":"Modlin","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2025.100462_bib0039","first-page":"1","article-title":"Using reduced inoculum densities of Mycobacterium tuberculosis in MGIT pyrazinamide susceptibility testing to prevent false-resistant results and improve accuracy: a multicenter evaluation","volume":"2017","author":"Morlock","year":"2017","journal-title":"Tuberc. Res. Treat."},{"issue":"12","key":"10.1016\/j.crmicr.2025.100462_bib0040","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1128\/JCM.01437-17","article-title":"Improved bactec MGIT 960 pyrazinamide test decreases detection of false Mycobacterium tuberculosis pyrazinamide resistance","volume":"55","author":"Mustazzolu","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0041","article-title":"Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 system","volume":"55","author":"Mustazzolu","year":"2019","journal-title":"Ann. Dell\u2019Istituto Super. Sanita"},{"key":"10.1016\/j.crmicr.2025.100462_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2021.100886","article-title":"Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study","volume":"42","author":"Nasiri","year":"2021","journal-title":"New. Microbes. New. Infect."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0043","article-title":"Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture","volume":"20","author":"Nimmo","year":"2019","journal-title":"BMC Genom."},{"issue":"12","key":"10.1016\/j.crmicr.2025.100462_bib0044","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00967-15","article-title":"Uncoupling environmental pH and intrabacterial acidification from pyrazinamide susceptibility in Mycobacterium tuberculosis","volume":"59","author":"Peterson","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0650-x","article-title":"Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs","volume":"11","author":"Phelan","year":"2019","journal-title":"Genome Med."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100462_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.68.8.4518-4522.2000","article-title":"Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg2+ levels","volume":"68","author":"Piddington","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.crmicr.2025.100462_bib0047","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/JCM.01838-12","article-title":"Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the bactec MGIT 960 system using a reduced inoculum","volume":"(1):","author":"Piersimoni","year":"2013","journal-title":"J. Clin. Microbiol. 51"},{"key":"10.1016\/j.crmicr.2025.100462_bib0048","series-title":"Guidelines for Programmatic Management of Drug-resistant TB in India","year":"2021"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0049","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1533-z","article-title":"The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?","volume":"16","author":"Pullan","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.crmicr.2025.100462_bib0050","article-title":"Mutations associated with pyrazinamide resistance in mycobacterium tuberculosis: a review and update","volume":"79","author":"Rajendran","year":"2022"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03452-y","article-title":"A multinational analysis of mutations and heterogeneity in PZase, RpsA, and PanD associated with pyrazinamide resistance in M\/XDR Mycobacterium tuberculosis","volume":"7","author":"Ramirez-Busby","year":"2017","journal-title":"Sci. Rep."},{"issue":"39","key":"10.1016\/j.crmicr.2025.100462_bib0052","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1907631116","article-title":"Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance","volume":"116","author":"Safi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"7","key":"10.1016\/j.crmicr.2025.100462_bib0053","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/AAC.32.7.1002","article-title":"Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method","volume":"32","author":"Salfinger","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.crmicr.2025.100462_bib0054","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01594-21","article-title":"Mycobacterium tuberculosis lineages associated with mutations and drug resistance in isolates from India","volume":"10","author":"Shanmugam","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"3","key":"10.1016\/j.crmicr.2025.100462_bib0055","article-title":"Interpretation of the World Health Organization\u2019s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition)","volume":"46","author":"Shaojun","year":"2024","journal-title":"Chin. J. Antituberc."},{"issue":"7","key":"10.1016\/j.crmicr.2025.100462_bib0056","first-page":"72","article-title":"Comparison of MGIT 960 & pyrazinamidase activity assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis","volume":"132","author":"Sharma","year":"2010","journal-title":"Indian J. Med. Res."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100462_bib0057","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkq186","article-title":"Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis","volume":"65","author":"Sharma","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.crmicr.2025.100462_bib0058","doi-asserted-by":"crossref","DOI":"10.2147\/IDR.S368444","article-title":"Pyrazinamide resistance and pncA mutation profiles in multidrug resistant mycobacterium tuberculosis","volume":"15","author":"Shi","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.crmicr.2025.100462_bib0059","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2147\/IDR.S260161","article-title":"Pyrazinamide resistance and mutation patterns among multidrug-resistant Mycobacterium tuberculosis from Henan Province","volume":"13","author":"Shi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.crmicr.2025.100462_bib0060","first-page":"1","article-title":"Identification of novel mutations in lprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 associated with pyrazinoic acid\/pyrazinamide resistance in Mycobacterium tuberculosis","author":"Shi","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2025.100462_bib0061","author":"Siddiqi"},{"issue":"24","key":"10.1016\/j.crmicr.2025.100462_bib0062","doi-asserted-by":"crossref","DOI":"10.1128\/JB.184.24.6796-6802.2002","article-title":"Regulation of expression of mas and fadD28, two genes involved in production of dimycocerosyl phthiocerol, a virulence factor of Mycobacterium tuberculosis","volume":"184","author":"Sirakova","year":"2002","journal-title":"J. Bacteriol."},{"issue":"6","key":"10.1016\/j.crmicr.2025.100462_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.43.6.2996-2997.2005","article-title":"Extraction of Mycobacterium tuberculosis DNA: a question of containment","volume":"43","author":"Somerville","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.crmicr.2025.100462_bib0064","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1128\/AAC.05385-11","article-title":"Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis","volume":"56","author":"Stoffels","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0065","first-page":"1","article-title":"The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis panD","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmicr.2025.100462_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1515627","article-title":"Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance\u2014India, 2018\u20132020","volume":"15","author":"Tamilzhalagan","year":"2025","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0067","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/JCM.01903-13","article-title":"Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China","volume":"52","author":"Tan","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.crmicr.2025.100462_bib0068","article-title":"Pyrazinamide action is driven by the cell envelope stress response in Mycobacterium tuberculosis","author":"Thiede","year":"2021","journal-title":"bioRxiv."},{"issue":"6","key":"10.1016\/j.crmicr.2025.100462_bib0069","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13060563","article-title":"Biphasic medium using nicotinamide for detection of pyrazinamide resistance in Mycobacterium tuberculosis","volume":"13","author":"Thuansuwan","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147529","article-title":"Pattern of drug resistance and risk factors associated with development of drug-resistant Mycobacterium tuberculosis in Pakistan","volume":"11","author":"Ullah","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.crmicr.2025.100462_bib0071","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/1120009X.2023.2214473","article-title":"Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis","volume":"35","author":"Wang","year":"2023","journal-title":"J. Chemother."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100462_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10080909","article-title":"Activity of pyrazinamide against Mycobacterium tuberculosis at neutral pH in PZA-S1 minimal medium","volume":"10","author":"Shi","year":"2021","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.crmicr.2025.100462_bib0073","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/JCM.02532-16","article-title":"Non-pncA gene-mutated but pyrazinamide-resistant mycobacterium tuberculosis: why is that?","volume":"55","author":"Werngren","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.crmicr.2025.100462_bib0074","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00720-21","article-title":"Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis","volume":"65","author":"Werngren","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.crmicr.2025.100462_bib0075","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/AAC.05894-11","article-title":"Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing","volume":"56","author":"Werngren","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.crmicr.2025.100462_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0133869","article-title":"A global perspective on pyrazinamide resistance: systematic review and meta-analysis","volume":"10","author":"Whitfield","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crmicr.2025.100462_bib0078","series-title":"Catalogue of Mutations in Mycobacterium tuberculosis Complex and their Association with Drug Resistance","year":"2021"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0079","article-title":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis Geneva: world Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO","volume":"6","year":"2018","journal-title":"Guideline"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0080","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int. J. Tuberc. Lung Dis. J. Int. Union Tuberc. Lung Dis"},{"issue":"1","key":"10.1016\/j.crmicr.2025.100462_bib0081","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1099\/0022-1317-51-1-42","article-title":"Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide","volume":"51","author":"Zhang","year":"2002","journal-title":"J. Med. Microbiol."},{"issue":"5","key":"10.1016\/j.crmicr.2025.100462_bib0082","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jac\/dkg446","article-title":"Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid","volume":"52","author":"Zhang","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.crmicr.2025.100462_bib0083","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00940-17","article-title":"Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008, and Rv1667c involved in pyrazinamide resistance in Mycobacterium tuberculosis","volume":"61","author":"Zhang","year":"2017","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517425001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517425001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:04:39Z","timestamp":1778040279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666517425001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":82,"alternative-id":["S2666517425001233"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2025.100462","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing diagnostic efficiency of pyrazinamide resistance in Mycobacterium tuberculosis via modified MGIT assay and genotypic correlation","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2025.100462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100462"}}